Health Care
Alexion Pharma stock jumps after Q4 results top expectations
Benefitting from the continued sales growth across all markets, led by cancer drug Soliris, Alexion Pharma (ALXN) Monday reported a…
Earnings Preview: Soliris to drive Alexion’s Q4 topline
Alexion Pharmaceuticals Inc. (ALXN) is set to report fourth-quarter 2018 earnings results on Monday, February 4, before market open. Wall…
Earnings preview: HIV to drive topline growth for Gilead Sciences in Q4
Biotechnology company Gilead Sciences (GILD) is scheduled to report fourth-quarter earnings results after the closing bell on Monday, February 4.…
Merck’s stock gains after Q4 results beat estimates
Merck’s (MRK) shares climbed over 3% in morning trade on Friday after the company topped revenue and earnings expectations for…
Cigna’s stock falls despite Q4 results beat
Cigna Corporation (CI) topped market expectations on revenue and earnings for the fourth quarter of 2018. Despite the beat, the…
Celgene posts upbeat Q4 results, guidance
Celgene Corp. (CELG) swung to a profit in the fourth quarter from a loss last year, helped by lower research…
Earnings preview: Merck to ride the wave of expanding oncology portfolio in Q4
The general market sentiment on Merck & Co. (MRK) is quite bullish ahead of the drug maker’s fourth-quarter earnings report.…
Anthem’s stock gains 6% after Q4 results top expectations
Anthem Inc. (ANTM) reported better-than-expected revenue and earnings for the fourth quarter of 2018, sending the stock up over 6%…
Amgen swings to profit in Q4, beats estimates
Amgen (AMGN) swung to a profit in the fourth quarter from a loss last year, helped by higher revenues, lower…
Illumina Q4 earnings miss estimates
Gene-sequencing firm Illumina (NASDAQ: ILMN) reported mixed Q4 results. The company failed to beat street estimates on the earnings front…